NR3C1 encodes the glucocorticoid receptor (GR) and regulates stress responses, metabolism, immune function, and inflammation, ...
Punjab’s Drugs Control Directorate warns that lab tests found three medicines substandard or adulterated. Authorities order ...
The NR3C1 (nuclear receptor subfamily 3 group C member 1) gene encodes the glucocorticoid receptor (GR), a nuclear receptor vital for maintaining physiological homeostasis, and inhibition of NR3C1 ...
The FDA review of the biologics license application includes data on SC isatuximab as both manual injection and via an ...
Results from the MagnetisMM-5 study showed that Elrexfio significantly improved progression-free survival, which means ...
Oculis Holding AG recently completed the final patient visits in its two Phase 3 DIAMOND trials of OCS-01, a topical dexamethasone eye drop being studied over 52 weeks as a potential first ...
Oculis Holding AG announced that the final patient visit has been completed in the DIAMOND phase 3 program assessing OCS-01, ...
In a preclinical CDX (cell line-derived xenograft) model, ISM6200 demonstrated significant and dose-dependent enhancement of anti-tumor efficacy when combined with paclitaxel. Also, a favorable ADME ...
In Europe, the SC formulation of daratumumab, another anti-CD38 antibody, recently received a label update that allowed ...
Pfizer announces positive results from phase 3 MagnetisMM-5 study of Elrexfio as monotherapy in adults with relapsed or refractory multiple myeloma: New York Thursday, April 30, 2 ...
Pfizer Inc. today announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO® (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results